Assignee
DECIPHERA PHARMACEUTICALS LLC
US·81 granted patents·49 pending applications·2,005 citations·filing 2003–2025
Top patents by PatentIndex Score
130 records- 0198US11813251B2Methods of treating gastrointestinal stromal tumorsDECIPHERA PHARMACEUTICALS LLC·Filed 2022·Granted Nov 14, 2023·15 cites·4 claims
- 0298US11793795B2Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3-phenylureaDECIPHERA PHARMACEUTICALS LLC·Filed 2023·Granted Oct 24, 2023·13 cites·10 claims
- 0398US11612591B2Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3-phenylureaDECIPHERA PHARMACEUTICALS LLC·Filed 2022·Granted Mar 28, 2023·31 cites·11 claims
- 0498US11576903B2Amorphous kinase inhibitor formulations and methods of use thereofDECIPHERA PHARMACEUTICALS LLC·Filed 2021·Granted Feb 14, 2023·31 cites·12 claims
- 0598US11576904B2Methods of treating gastrointestinal stromal tumorsDECIPHERA PHARMACEUTICALS LLC·Filed 2022·Granted Feb 14, 2023·33 cites·1 claims
- 0698US11534432B2Methods of treating gastrointestinal stromal tumorsDECIPHERA PHARMACEUTICALS LLC·Filed 2022·Granted Dec 27, 2022·34 cites·4 claims
- 0798US11529336B2Methods of treating gastrointestinal stromal tumorsDECIPHERA PHARMACEUTICALS LLC·Filed 2022·Granted Dec 20, 2022·31 cites·2 claims
- 0898US11433056B1Methods of treating gastrointestinal stromal tumorsDECIPHERA PHARMACEUTICALS LLC·Filed 2022·Granted Sep 6, 2022·31 cites·3 claims
- 0998US11426390B2Methods of treating gastrointestinal stromal tumorsDECIPHERA PHARMACEUTICALS LLC·Filed 2022·Granted Aug 30, 2022·36 cites·6 claims
- 1098US11395818B2Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3-phenylureaDECIPHERA PHARMACEUTICALS LLC·Filed 2021·Granted Jul 26, 2022·36 cites·3 claims
- 1198US11344536B1Methods of treating gastrointestinal stromal tumorsDECIPHERA PHARMACEUTICALS LLC·Filed 2022·Granted May 31, 2022·37 cites·3 claims
- 1298US11266635B2Methods of treating gastrointestinal stromal tumorsDECIPHERA PHARMACEUTICALS LLC·Filed 2021·Granted Mar 8, 2022·39 cites·3 claims
- 1398US11185535B2Amorphous kinase inhibitor formulations and methods of use thereofDECIPHERA PHARMACEUTICALS LLC·Filed 2021·Granted Nov 30, 2021·39 cites·1 claims
- 1498USRE48731EDihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseasesDECIPHERA PHARMACEUTICALS LLC·Filed 2019·Granted Sep 14, 2021·36 cites·21 claims
- 1598US10966966B2Methods of treating gastrointestinal stromal tumorsDECIPHERA PHARMACEUTICALS LLC·Filed 2020·Granted Apr 6, 2021·46 cites·3 claims
- 1698US9012635B2Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activitiesDECIPHERA PHARMACEUTICALS LLC·Filed 2014·Granted Apr 21, 2015·61 cites·34 claims
- 1798US7666895B2Anti-inflammatory medicamentsDECIPHERA PHARMACEUTICALS LLC·Filed 2006·Granted Feb 23, 2010·85 cites·8 claims
- 1898US7531566B2Anti-inflammatory medicamentsDECIPHERA PHARMACEUTICALS LLC·Filed 2006·Granted May 12, 2009·77 cites·8 claims
- 1998US7342037B2Anti-inflammatory medicamentsDECIPHERA PHARMACEUTICALS LLC·Filed 2006·Granted Mar 11, 2008·81 cites·13 claims
- 2098US7144911B2Anti-inflammatory medicamentsDECIPHERA PHARMACEUTICALS LLC·Filed 2003·Granted Dec 5, 2006·127 cites·8 claims
- 2197US11801237B2Amorphous kinase inhibitor formulations and methods of use thereofDECIPHERA PHARMACEUTICALS LLC·Filed 2023·Granted Oct 31, 2023·13 cites·2 claims
- 2297US11779572B1Methods of treating gastrointestinal stromal tumorsDECIPHERA PHARMACEUTICALS LLC·Filed 2022·Granted Oct 10, 2023·14 cites·5 claims
- 2397US11590134B2Aminopyrimidine amide autophagy inhibitors and methods of use thereofDECIPHERA PHARMACEUTICALS LLC·Filed 2020·Granted Feb 28, 2023·19 cites·20 claims
- 2497US11530206B2Phenylaminopyrimidine amide autophagy inhibitors and methods of use thereofDECIPHERA PHARMACEUTICALS LLC·Filed 2020·Granted Dec 20, 2022·20 cites·37 claims
- 2597US11518758B2Heteroarylaminopyrimidine amide autophagy inhibitors and methods of use thereofDECIPHERA PHARMACEUTICALS LLC·Filed 2020·Granted Dec 6, 2022·16 cites·20 claims
- 2697US9387202B2Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activitiesDECIPHERA PHARMACEUTICALS LLC·Filed 2014·Granted Jul 12, 2016·60 cites·2 claims
- 2797US9309224B2N-acyl-N′-(pyridin-2-yl) ureas and analogs exhibiting anti-cancer and anti-proliferative activitiesDECIPHERA PHARMACEUTICALS LLC·Filed 2014·Granted Apr 12, 2016·60 cites·40 claims
- 2897US9187474B2Raf inhibitor compoundsDECIPHERA PHARMACEUTICALS LLC·Filed 2013·Granted Nov 17, 2015·60 cites·19 claims
- 2997US7897762B2Kinase inhibitors useful for the treatment of proliferative diseasesDECIPHERA PHARMACEUTICALS LLC·Filed 2007·Granted Mar 1, 2011·59 cites·93 claims
- 3097US7790756B2Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseasesDECIPHERA PHARMACEUTICALS LLC·Filed 2007·Granted Sep 7, 2010·79 cites·22 claims
- 3197US7737283B2Anti-inflammatory medicamentsDECIPHERA PHARMACEUTICALS LLC·Filed 2006·Granted Jun 15, 2010·63 cites·10 claims
- 3297US7202257B2Anti-inflammatory medicamentsDECIPHERA PHARMACEUTICALS LLC·Filed 2004·Granted Apr 10, 2007·107 cites·3 claims
- 3396US12285430B2Methods of treating disorders using CSF1R inhibitorsDECIPHERA PHARMACEUTICALS LLC·Filed 2023·Granted Apr 29, 2025·4 cites·18 claims
- 3496US11679110B2Methods of treating disorders using CSF1R inhibitorsDECIPHERA PHARMACEUTICALS LLC·Filed 2021·Granted Jun 20, 2023·24 cites·18 claims
- 3596US11103507B2Methods of treating disorders using CSF1R inhibitorsDECIPHERA PHARMACEUTICALS LLC·Filed 2019·Granted Aug 31, 2021·48 cites·30 claims
- 3696US9193719B21,2,4-triazol-5-ones and analogs exhibiting anti-cancer and anti-proliferative activitiesDECIPHERA PHARMACEUTICALS LLC·Filed 2014·Granted Nov 24, 2015·60 cites·36 claims
- 3796US9181223B22-aminopyrimidin-6-ones and analogs exhibiting anti-cancer and anti-proliferative activitiesDECIPHERA PHARMACEUTICALS LLC·Filed 2014·Granted Nov 10, 2015·62 cites·29 claims
- 3896US9133183B2Imidazolidinones and analogs exhibiting anti-cancer and anti-proliferative activitiesDECIPHERA PHARMACEUTICALS LLC·Filed 2014·Granted Sep 15, 2015·60 cites·32 claims
- 3995US12509443B2CSF-1R inhibitors and methods of use thereofDECIPHERA PHARMACEUTICALS LLC·Filed 2025·Granted Dec 30, 2025·1 cites·21 claims
- 4095US9457019B2Methods for inhibiting tie-2 kinase useful in the treatment of cancerDECIPHERA PHARMACEUTICALS LLC·Filed 2014·Granted Oct 4, 2016·70 cites·42 claims
- 4195US9382228B2N-acyl-N′-(pyridin-2-yl) ureas and analogs exhibiting anti-cancer and anti-proliferative activitiesDECIPHERA PHARMACEUTICALS LLC·Filed 2014·Granted Jul 5, 2016·60 cites·43 claims
- 4295US9334267B2RAF inhibitor compoundsDECIPHERA PHARMACEUTICALS LLC·Filed 2013·Granted May 10, 2016·60 cites·17 claims
- 4395US7279576B2Anti-cancer medicamentsDECIPHERA PHARMACEUTICALS LLC·Filed 2003·Granted Oct 9, 2007·67 cites·3 claims
- 4493US12226406B2Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylureaDECIPHERA PHARMACEUTICALS LLC·Filed 2024·Granted Feb 18, 2025·0 cites·13 claims
- 4592US12318374B2Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylureaDECIPHERA PHARMACEUTICALS LLC·Filed 2024·Granted Jun 3, 2025·0 cites·24 claims
- 4692US12318373B2Methods of treating gastrointestinal stromal tumorsDECIPHERA PHARMACEUTICALS LLC·Filed 2024·Granted Jun 3, 2025·0 cites·3 claims
- 4792US12295944B2Methods of treating gastrointestinal stromal tumorsDECIPHERA PHARMACEUTICALS LLC·Filed 2024·Granted May 13, 2025·0 cites·1 claims
- 4892US12213968B2Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylureaDECIPHERA PHARMACEUTICALS LLC·Filed 2024·Granted Feb 4, 2025·0 cites·18 claims
- 4992US12213967B2Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylureaDECIPHERA PHARMACEUTICALS LLC·Filed 2024·Granted Feb 4, 2025·0 cites·11 claims
- 5092US2025387380A1Amorphous kinase inhibitor formulations and methods of use thereofDECIPHERA PHARMACEUTICALS LLC·Filed 2025·Application pending·0 cites
Showing the top 50 of 130 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →